Breaking News Instant updates and real-time market news.

2021-03-09 04:55:00 ICFI ICF International $89.01 / +1.42 (+1.62%) 04:55 03/09/21 03/09 04:55 03/09/21 04:55	ICF International management to meet virtually with Barrington Virtual Meeting to be held on March 9 hosted by Barrington.	09 Mar
ICFI ICF International $89.01 / +1.42 (+1.62%) 03/03/21 Barrington ICF International price target raised to $96 from $88 at Barrington 02/26/21 Canaccord ICF International price target raised to $100 from $80 at Canaccord 01/15/21 Truist ICF International price target raised to $102 from $95 at Truist 01/06/21 Barrington Imax and Sirius XM among Barrington's best ideas for 2021

2021-03-09 04:55:00

ICFI

ICF International

$89.01 / +1.42 (+1.62%)

04:55

03/09/21

03/09

04:55

03/09/21

04:55

ICF International management to meet virtually with Barrington

Virtual Meeting to be held on March 9 hosted by Barrington.

09
Mar

ICFI ICF International

$89.01 / +1.42 (+1.62%)

03/03/21 Barrington: ICF International price target raised to $96 from $88 at Barrington

02/26/21 Canaccord: ICF International price target raised to $100 from $80 at Canaccord

01/15/21 Truist: ICF International price target raised to $102 from $95 at Truist

01/06/21 Barrington: Imax and Sirius XM among Barrington's best ideas for 2021

TODAY'S FREE FLY STORIES

Hot Stocks	CHF Solutions expands access to ultrafiltration therapy in Texas hospitals » 08:17 04/23/21 04/23 08:17 04/23/21 08:17 CHFS CHF Solutions $5.03 / -0.02 (-0.40%) CHF Solutions announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CHFS CHF Solutions $5.03 / -0.02 (-0.40%) 04/20/21 CHF Solutions announces enrollment of first patient in ULTRA-Peds Registry 04/08/21 CHF Solutions announces evidence on Aquadex SmartFlow system 03/11/21 CHF Solutions submits patent application for peripheral venous access technology 03/09/21 CHF Solutions expands access to ultrafiltration therapy in Puerto Rico CHFS CHF Solutions $5.03 / -0.02 (-0.40%) 10/21/20 Maxim CHF Solutions price target lowered to $20 from $45 at Maxim 06/05/20 Maxim CHF Solutions initiated with a Buy at Maxim CHFS CHF Solutions $5.03 / -0.02 (-0.40%) 11/10/20 CHF Solutions reports Q3 revenue $1.9M vs. $1.3M last year 17 Mar 05/19/21 CHF Solutions, Inc.
Earnings	Clearfield reports Q2 EPS 27c, consensus 17c » 08:17 04/23/21 04/23 08:17 04/23/21 08:17 CLFD Clearfield $29.93 / +0.16 (+0.54%) Last night reported Q2… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CLFD Clearfield $29.93 / +0.16 (+0.54%) 08:13 Today Northland Clearfield upgraded to Outperform from Market Perform at Northland 01/29/21 Lake Street Clearfield price target raised to $37 from $25 at Lake Street 01/29/21 Northland Clearfield downgraded to Market Perform from Outperform at Northland 12/08/20 Northland Clearfield price target raised to $26 from $24 at Northland
Hot Stocks	Vaxart appoints David Wheadon to its board of directors » 08:17 04/23/21 04/23 08:17 04/23/21 08:17 VXRT Vaxart $5.75 / +0.17 (+3.05%) , AZN AstraZeneca $52.73 / -0.38 (-0.72%) Vaxart (VXRT) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VXRT AZN VXRT Vaxart $5.75 / +0.17 (+3.05%) 04/22/21 Vaxart announces results of survey on COVID-19 vaccine pill 02/03/21 Vaxart trading resumes 02/03/21 Vaxart trading halted, volatility trading pause 02/03/21 Vaxart announces preliminary data from Phase 1 trial of oral COVID-19 tablet AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/20/21 EMA recommends clot warning for J&J vaccine, says benefit still positive 04/19/21 Emergent stops manufacturing at Baltimore facility after FDA inspection 04/16/21 AstraZeneca reports U.S. clearance of proposed acquisition of Alexion 04/14/21 Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine VXRT AZN VXRT Vaxart $5.75 / +0.17 (+3.05%) 03/04/21 B. Riley Securities Vaxart price target lowered to $13 from $16 at B. Riley Securities 11/18/20 B. Riley Securities Vaxart price target lowered to $16 from $22 at B. Riley Securities 10/13/20 B. Riley Securities B. Riley views Vaxart as key player in 'second wave' of Covid vaccines 09/09/20 B. Riley FBR Astra trial hold opens window for other vaccine candidates, says B. Riley FBR AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/12/21 Fly Intel: Top five analyst downgrades 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 04/12/21 Argus AstraZeneca downgraded to Hold from Buy at Argus VXRT AZN VXRT Vaxart $5.75 / +0.17 (+3.05%) 11/12/20 Vaxart reports Q3 EPS (8c), consensus (9c) AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/07/21 EMA says benefits of AstraZeneca Covid vaccine outweigh side effects 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage AZN AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/21/21 EU snubs extra 300M J&J, AstraZeneca COVID vaccines, Reuters reports 04/20/21 J&J to cooperate in study of blood clots linked to COVID shot, Reuters says 04/18/21 Canada's Ontario to expand use of AstraZeneca COVID vaccine, Reuters says 04/16/21 J&J reached out to vaccine rivals to study blood clot risk, WSJ reports VXRT AZN VXRT Vaxart $5.75 / +0.17 (+3.05%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/16/21 Fly Intel: Wall Street's top stories for Friday 04/16/21 Fly Intel: Wall Street's top stories at midday 04/16/21 Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/30/21 AstraZeneca - AZN 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease VXRT AZN VXRT Vaxart $5.75 / +0.17 (+3.05%) 03/16/21 Vaxart call volume above normal and directionally bullish 02/25/21 Vaxart options imply 19.5% move in share price post-earnings 02/05/21 Largest borrow rate increases among liquid names 01/29/21 Vaxart call volume above normal and directionally bullish AZN AstraZeneca $52.73 / -0.38 (-0.72%) 04/22/21 AstraZeneca call volume above normal and directionally bullish 04/01/21 AstraZeneca put volume heavy and directionally bearish 03/22/21 AstraZeneca call volume above normal and directionally bullish 03/16/21 Unusually active option classes on open March 16th
Earnings	First Hawaiian reports Q1 EPS 44c, consensus 44c » 08:16 04/23/21 04/23 08:16 04/23/21 08:16 FHB First Hawaiian $27.05 / -0.09 (-0.33%) Total assets were $23.5… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FHB First Hawaiian $27.05 / -0.09 (-0.33%) 04/22/21 First Hawaiian names Christopher Dods as COO 02/08/21 First Hawaiian announces up to $75M stock repurchase program FHB First Hawaiian $27.05 / -0.09 (-0.33%) 11/19/20 JPMorgan First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo FHB First Hawaiian $27.05 / -0.09 (-0.33%) 01/22/21 First Hawaiian reports Q4 core EPS 50c, consensus 44c 13:00 Today First Hawaiian - FHB
Hot Stocks	Inovio sinks after Department of Defense stops vaccine trial funding » 08:15 04/23/21 04/23 08:15 04/23/21 08:15 INO Inovio $9.13 / -0.02 (-0.22%) Shares of Inovio are… Shares of Inovio are sinking after the Department of Defense decided to stop funding the company's Covid-19 vaccine trial in the U.S. The Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense told Inovio that it will discontinue funding for the Phase 3 segment of the INNOVATE trial, while continuing to fund the completion of the ongoing Phase 2 segment. In correspondence, JPEO informed Inovio: "The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines. This decision is not a reflection of the awardee or product, rather a fast-moving environment associated with the former Operation Warp Speed on decisions related to future products." The decision does not impact other work that Inovio does with the U.S. government and is neither a result of the partial clinical hold nor a reflection of the data generated to date for INO-4800 vaccine, the company said in a statement. The company is planning for a predominantly outside the U.S. Phase 3 trial based on upcoming evaluation of Phase 2 safety and immunogenicity data. Inovio shares in premarket trading are down 23%, or $2.13, to $7.00. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options INO Inovio $9.13 / -0.02 (-0.22%) 08:05 Today Inovio planning for ex-U.S. global Phase 3 trial for INO-4800 04/15/21 Inovio's COVID-19 vaccine candidate shows response against all tested variants 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic INO Inovio $9.13 / -0.02 (-0.22%) 03/23/21 Fly Intel: Top five analyst initiations 03/23/21 BofA Inovio initiated with a Neutral at BofA 03/02/21 Piper Sandler Piper lowers Inovio target to $7 after 'decidedly negative' update 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target INO Inovio $9.13 / -0.02 (-0.22%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $9.13 / -0.02 (-0.22%) 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 05/13/21 Inovio Pharmaceuticals, Inc INO Inovio $9.13 / -0.02 (-0.22%) 04/20/21 Largest borrow rate increases among liquid names 04/15/21 Unusually active option classes on open April 15th 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish

Hot Stocks	Yunji announces appointment of Wei Ye as executive president » 08:15 04/23/21 04/23 08:15 04/23/21 08:15 YJ Yunji $2.00 / -0.035 (-1.72%) Yunji announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly YJ Yunji $2.00 / -0.035 (-1.72%) 11/24/20 Yunji to partner with Douyin YJ Yunji $2.00 / -0.035 (-1.72%) 11/30/20 Morgan Stanley Yunji downgraded to Underweight from Equal Weight at Morgan Stanley YJ Yunji $2.00 / -0.035 (-1.72%) 11/24/20 Fly Intel: After-Hours Movers
Earnings	Gentex sees 2022 revenue 8%-13% higher than 2021 revenue, consensus $2.18B » 08:14 04/23/21 04/23 08:14 04/23/21 08:14 GNTX Gentex $35.62 / -0.51 (-1.41%) Based on the mid-April… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GNTX Gentex $35.62 / -0.51 (-1.41%) 01/12/21 Gentex announces nanofiber sensing technology 01/11/21 Gentex announces partnership with Simplenight 11/30/20 Gentex, PayByCar announce partnership for in-vehicle payments GNTX Gentex $35.62 / -0.51 (-1.41%) 02/01/21 B. Riley Securities Gentex price target raised to $40 from $38.75 at B. Riley Securities 01/28/21 Fly Intel: Top five analyst initiations 01/28/21 Seaport Global Seaport starts Gentex with Neutral, awaits better entry point 01/28/21 Seaport Global Gentex initiated with a Neutral at Seaport Global GNTX Gentex $35.62 / -0.51 (-1.41%) 08:12 Today Gentex sees 2021 revenue $1.94B-$2.02B, consensus $2B 08:11 Today Gentex reports Q1 EPS 46c, consensus 49c 01/29/21 Gentex sees 2021 revenue $1.94B-$2.02B, consensus $1.95B 01/29/21 Gentex reports Q4 EPS 58c, consensus 50c 09:30 Today Gentex - GNTX 05/20/21 Gentex Corporation
Upgrade	Clearfield upgraded to Outperform from Market Perform at Northland » 08:13 04/23/21 04/23 08:13 04/23/21 08:13 CLFD Clearfield $29.93 / +0.16 (+0.54%) Northland analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CLFD Clearfield $29.93 / +0.16 (+0.54%) 01/29/21 Lake Street Clearfield price target raised to $37 from $25 at Lake Street 01/29/21 Northland Clearfield downgraded to Market Perform from Outperform at Northland 12/08/20 Northland Clearfield price target raised to $26 from $24 at Northland 12/08/20 Northland Calix price target raised to $30 from $28 at Northland
Earnings	Gentex sees 2021 revenue $1.94B-$2.02B, consensus $2B » 08:12 04/23/21 04/23 08:12 04/23/21 08:12 GNTX Gentex $35.62 / -0.51 (-1.41%) The Company's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GNTX Gentex $35.62 / -0.51 (-1.41%) 01/12/21 Gentex announces nanofiber sensing technology 01/11/21 Gentex announces partnership with Simplenight 11/30/20 Gentex, PayByCar announce partnership for in-vehicle payments GNTX Gentex $35.62 / -0.51 (-1.41%) 02/01/21 B. Riley Securities Gentex price target raised to $40 from $38.75 at B. Riley Securities 01/28/21 Fly Intel: Top five analyst initiations 01/28/21 Seaport Global Seaport starts Gentex with Neutral, awaits better entry point 01/28/21 Seaport Global Gentex initiated with a Neutral at Seaport Global GNTX Gentex $35.62 / -0.51 (-1.41%) 08:11 Today Gentex reports Q1 EPS 46c, consensus 49c 01/29/21 Gentex sees 2021 revenue $1.94B-$2.02B, consensus $1.95B 01/29/21 Gentex reports Q4 EPS 58c, consensus 50c 09:30 Today Gentex - GNTX 05/20/21 Gentex Corporation
Upgrade	Imax upgraded to Outperform from Neutral at Wedbush » 08:12 04/23/21 04/23 08:12 04/23/21 08:12 IMAX Imax $21.32 / +0.18 (+0.85%) Wedbush analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IMAX Imax $21.32 / +0.18 (+0.85%) 04/21/21 Imax announces five-picture agreement with Imagine Documentaries 04/19/21 NY Governor says movie theater capacity to be raised to 33% next week 03/30/21 Brad Wechsler stepping down as chairman of IMAX 03/23/21 Disney confirms 'Cruella' and 'Black Widow' to debut in theaters and on Disney+ IMAX Imax $21.32 / +0.18 (+0.85%) 04/05/21 B. Riley Securities B. Riley upgrades AMC to Buy with $13 target after 'impressive' weekend 03/24/21 B. Riley Securities Disney 'day-and-date' decision negative for exhibitors, says B. Riley 03/09/21 Barrington Imax price target raised to $27 from $25 at Barrington 03/05/21 Macquarie Imax price target raised to $25 after Q4 earnings beat at Macquarie IMAX Imax $21.32 / +0.18 (+0.85%) 03/04/21 Imax reports Q4 adjusted EPS (21c), consensus (20c) 10/29/20 Imax reports Q3 EPS (75c), consensus (30c) IMAX Imax $21.32 / +0.18 (+0.85%) 03/23/21 Disney to put 'Black Widow' on Disney+ same day as theaters, Deadline says 03/12/21 L.A. County officials say movie theaters can reopen Monday, Deadline says 03/10/21 Movie theaters in L.A. could reopen as early as Saturday, CNBC reports 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says IMAX Imax $21.32 / +0.18 (+0.85%) 04/05/21 Analyst says buy AMC after 'impressive' weekend at the box office 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/15/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 Imax - IMAX IMAX Imax $21.32 / +0.18 (+0.85%) 01/05/21 Largest borrow rate increases among liquid names 11/10/20 IMAX call buyer realizes 525% same-day gains 10/23/20 Largest borrow rate increases among liquid names

Hot Stocks	MicroVision jumps another 7% in pre-market on WallStreetBets focus » 08:12 04/23/21 04/23 08:12 04/23/21 08:12 MVIS MicroVision $13.13 / +0.61 (+4.87%) Shares of Microvision are… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options MVIS MicroVision $13.13 / +0.61 (+4.87%) 03/31/21 MicroVision up 44% after Microsoft deal with U.S. Army for HoloLens headsets 03/11/21 MicroVision general counsel David Westgor to step down 03/02/21 MicroVision appoints Seval Oz to board of directors 02/16/21 MicroVision drops 10% to $21.34 after $50M at-the-market equity facility MVIS MicroVision $13.13 / +0.61 (+4.87%) 05/06/20 Craig-Hallum MicroVision rise driven by Microsoft speculation, says Craig-Hallum MVIS MicroVision $13.13 / +0.61 (+4.87%) 04/14/21 MicroVision change of control may mean 'deal door still open,' Dealreporter says 12/22/20 MicroVision called 'corporate husk,' named as short idea by Hindenburg MVIS MicroVision $13.13 / +0.61 (+4.87%) 02/16/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 Fly Intel: Pre-market Movers 04/29/21 MicroVision - MVIS 05/26/21 Microvision, Inc. MVIS MicroVision $13.13 / +0.61 (+4.87%) 04/22/21 Unusually active option classes on open April 22nd 04/21/21 Largest borrow rate increases among liquid names 04/20/21 Unusually active option classes on open April 20th 04/20/21 Largest borrow rate increases among liquid names
Hot Stocks	DLH Holdings wins $202M contract to provide medical logistics to the VA » 08:12 04/23/21 04/23 08:12 04/23/21 08:12 DLHC DLH Holdings $10.38 / +0.08 (+0.78%) DLH Holdings announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events Options DLHC DLH Holdings $10.38 / +0.08 (+0.78%) 01/11/21 DLH Holdings wins renewal of clinical suppoty to NIH-funded ACTG 12/07/20 DLH Holdings sees FY21 interest expense of $3M 11/05/20 DLH Holdings appoints Sandra Halverson as chief scientist DLHC DLH Holdings $10.38 / +0.08 (+0.78%) 12/07/20 DLH Holdings reports Q4 EPS 10c, two est. 15c 05/06/21 DLH Holdings - DLHC DLHC DLH Holdings $10.38 / +0.08 (+0.78%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Hot Stocks	Purple Biotech announces dosing of first patient in Phase 1b/2 trial of CM24 » 08:11 04/23/21 04/23 08:11 04/23/21 08:11 PPBT Purple Biotech $4.45 / -0.2 (-4.30%) Purple Biotech announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options PPBT Purple Biotech $4.45 / -0.2 (-4.30%) 04/13/21 Purple Biotech presents additional data for NT219 at AACR 2021 meeting 03/19/21 Purple Biotech initiates Phase 1b/2 trial of CM24 03/11/21 Purple Biotech to present additional data on NT219 at AACR meeting 03/03/21 Purple Biotech appoints Robert Gagnon to board of directors PPBT Purple Biotech $4.45 / -0.2 (-4.30%) 12/31/20 H.C. Wainwright H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech PPBT Purple Biotech $4.45 / -0.2 (-4.30%) 12/22/20 Four new option listings and six option delistings on December 22nd
Earnings	Gentex reports Q1 EPS 46c, consensus 49c » 08:11 04/23/21 04/23 08:11 04/23/21 08:11 GNTX Gentex $35.62 / -0.51 (-1.41%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GNTX Gentex $35.62 / -0.51 (-1.41%) 01/12/21 Gentex announces nanofiber sensing technology 01/11/21 Gentex announces partnership with Simplenight 11/30/20 Gentex, PayByCar announce partnership for in-vehicle payments GNTX Gentex $35.62 / -0.51 (-1.41%) 02/01/21 B. Riley Securities Gentex price target raised to $40 from $38.75 at B. Riley Securities 01/28/21 Fly Intel: Top five analyst initiations 01/28/21 Seaport Global Seaport starts Gentex with Neutral, awaits better entry point 01/28/21 Seaport Global Gentex initiated with a Neutral at Seaport Global GNTX Gentex $35.62 / -0.51 (-1.41%) 01/29/21 Gentex sees 2021 revenue $1.94B-$2.02B, consensus $1.95B 01/29/21 Gentex reports Q4 EPS 58c, consensus 50c 09:30 Today Gentex - GNTX 05/20/21 Gentex Corporation
Initiation	NIO initiated with a Buy at CLSA » 08:09 04/23/21 04/23 08:09 04/23/21 08:09 NIO NIO $39.60 / +0.7 (+1.80%) CLSA analyst Soobin Park… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options NIO NIO $39.60 / +0.7 (+1.80%) 04/14/21 Ford announces Mustang Mach-E made in China opens for pre-order 04/09/21 Tesla CEO offers 'congrats to NIO' on 100,000 vehicle milestone 04/01/21 NIO delivers 7,257 vehicles in March, 20,060 vehicles in Q1 03/26/21 NIO falls over 7.5% to $35.04 after suspending output due to parts shortage NIO NIO $39.60 / +0.7 (+1.80%) 04/20/21 Mizuho Tesla price target raised to $820 from $775 at Mizuho 03/11/21 Fly Intel: Top five analyst initiations 03/10/21 Mizuho Mizuho starts 'leader and innovator' NIO with Buy rating, $60 target 03/10/21 Mizuho NIO initiated with a Buy at Mizuho NIO NIO $39.60 / +0.7 (+1.80%) 03/01/21 NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M 03/01/21 NIO reports Q4 adjusted EPS (14c), consensus (7c) 11/17/20 NIO Inc. sees Q4 revenue $921.8M-$947.9M, consensus $805.66M 11/17/20 NIO Inc. reports Q3 adj. EPS (12c), consensus (17c) 14 Dec 31 Aug 11 Jun NIO NIO $39.60 / +0.7 (+1.80%) 01/28/21 NIO ES6 'rumored to be coming to Europe in 2021,' Electrek says 01/06/21 NIO plans to launch models with lithium iron phosphate batteries, CNEVPost says 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/07/20 QuantumScape battery tech could be 'huge' for EVs, Barron's reports NIO NIO $39.60 / +0.7 (+1.80%) 04/19/21 Charged: Walmart invests in GM-backed self-driving company Cruise 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries 03/29/21 Charged: Tesla accepting bitcoin as form of payment for cars 03/26/21 Fly Intel: Wall Street's top stories for Friday 04/29/21 NIO - NIO NIO NIO $39.60 / +0.7 (+1.80%) 04/16/21 Notable open interest changes for April 16th 04/08/21 Notable open interest changes for April 8th 03/29/21 Notable open interest changes for March 29th 03/26/21 Notable open interest changes for March 26th

Hot Stocks	Coherus says Toripalimab achieved primary endpoints in Phase 3 trial » 08:09 04/23/21 04/23 08:09 04/23/21 08:09 CHRS Coherus Biosciences $14.62 / -0.13 (-0.88%) Coherus BioSciences has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CHRS Coherus Biosciences $14.62 / -0.13 (-0.88%) 04/20/21 Coherus announces closing of $50M sale of common stock to Junshi 03/03/21 Junshi, Coherus BioSciences initiate rolling submission of BLA for toripalimab 02/17/21 Coherus Biosciences announces acceptance of BLA filing for CHS-1420 02/16/21 Coherus CFO Jean-Frederic Viret to resign CHRS Coherus Biosciences $14.62 / -0.13 (-0.88%) 02/25/21 Citi Coherus Biosciences price target lowered to $27 from $30 at Citi 02/25/21 H.C. Wainwright Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright 11/19/20 Mizuho Coherus Biosciences price target lowered to $30 from $35 at Mizuho 08/21/20 Mizuho Express Scripts exclusion does not impact Coherus, says Mizuho CHRS Coherus Biosciences $14.62 / -0.13 (-0.88%) 11/05/20 Coherus Biosciences reports Q3 EPS 47c, consensus 41c 05/21/21 Coherus Biosciences, Inc.
Hot Stocks	Athleta announces long-term partnership with Simone Biles » 08:09 04/23/21 04/23 08:09 04/23/21 08:09 GPS Gap $33.24 / +0.43 (+1.31%) Athleta, a Gap brand,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GPS Gap $33.24 / +0.43 (+1.31%) 04/20/21 Gap brand Athleta announces entry into Canada 04/13/21 Gap credit card program in agreements with Barclays and Mastercard 04/13/21 Synchrony says will not renew financing partnership with Gap 03/25/21 Gap agrees to sell Janie and Jack brand to Go Global Retail GPS Gap $33.24 / +0.43 (+1.31%) 04/19/21 JPMorgan Gap price target raised to $37 from $32 at JPMorgan 04/13/21 Morgan Stanley Synchrony loss of Gap card deal 'likely a positive,' says Morgan Stanley 03/15/21 Wells Fargo Gap price target raised to $40 from $32 at Wells Fargo 03/09/21 MKM Partners Gap price target raised to $29 from $21 at MKM Partners GPS Gap $33.24 / +0.43 (+1.31%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y GPS Gap $33.24 / +0.43 (+1.31%) 04/13/21 Barclays to replace Synchrony as Gap's credit-card issuer, WSJ reports 03/08/21 Gap mulling options, including possible sale, for China business, Bloomberg says 03/08/21 Gap said to consider sale of China business, Bloomberg says 03/05/21 Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports GPS Gap $33.24 / +0.43 (+1.31%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 05/11/21 Gap Inc. GPS Gap $33.24 / +0.43 (+1.31%) 04/22/21 Gap call volume above normal and directionally bullish 04/13/21 Gap put volume heavy and directionally bearish 04/12/21 Gap call buyer realizes 60% same-day gains 03/10/21 Gap call volume above normal and directionally bullish
Earnings	Coty backs FY21 revenue view $4.5B-$4.6B, consensus $4.57B » 08:08 04/23/21 04/23 08:08 04/23/21 08:08 COTY Coty $9.20 / +0.11 (+1.21%) Backs FY21 adjusted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options COTY Coty $9.20 / +0.11 (+1.21%) 04/20/21 Amazon steps into beauty business as it opens a Salon in London 03/03/21 Coty to partner with LanzaTech to pioneer new sustainable fragrance production 02/16/21 Coty up 2% afterhours following director buys 02/15/21 Fly Intel: Top five weekend stock stories COTY Coty $9.20 / +0.11 (+1.21%) 04/16/21 DA Davidson Coty price target raised to $9.25 from $6 at DA Davidson 02/10/21 Fly Intel: Top five analyst upgrades 02/10/21 Evercore ISI Evercore raises Coty to Outperform, says turnaround 'a question of when,' not if 02/10/21 Evercore ISI Coty upgraded to Outperform from In Line at Evercore ISI COTY Coty $9.20 / +0.11 (+1.21%) 02/09/21 Coty sees FY21 adjusted EBITDA $750M 02/09/21 Coty reports Q2 adjusted EPS 17c, consensus 7c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open COTY Coty $9.20 / +0.11 (+1.21%) 02/13/21 Time to buy Coty as stock tumbles after earnings, Barron's says COTY Coty $9.20 / +0.11 (+1.21%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 02/09/21 Fly Intel: Pre-market Movers 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades 08:00 Today Coty - COTY 05/10/21 Coty - COTY COTY Coty $9.20 / +0.11 (+1.21%) 04/15/21 Coty call volume above normal and directionally bullish 03/15/21 Coty call volume above normal and directionally bullish 02/24/21 Coty call volume above normal and directionally bullish 02/22/21 Coty call volume above normal and directionally bullish
Recommendations	HCA Healthcare price target raised to $230 from $200 at Oppenheimer » 08:06 04/23/21 04/23 08:06 04/23/21 08:06 HCA HCA Healthcare $201.52 / +3.96 (+2.00%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 02/24/21 Brookdale Senior Living to sell 80% stake in BHS to HCA Healthcare for $400M 01/26/21 HCA Healthcare uses Its COVID-19 registry to aid research in area 01/21/21 HCA Healthcare in new JV with A Plus International to expand PPE access 10/26/20 HCA Healthcare sees FY21 EBITDA $10.25B-$10.65B HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 07:16 Today Barclays HCA Healthcare price target raised to $225 from $195 at Barclays 07:00 Today Deutsche Bank HCA Healthcare price target raised to $225 from $210 at Deutsche Bank 06:50 Today Mizuho HCA Healthcare price target raised to $232 from $205 at Mizuho 06:45 Today RBC Capital HCA Healthcare price target raised to $232 from $205 at RBC Capital HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 04/22/21 HCA Healthcare raises FY21 EPS view to $13.30-$14.30 from $12.10-$13.10 04/22/21 HCA Healthcare reports Q1 EPS $4.14, consensus $3.32 04/21/21 Notable companies reporting before tomorrow's open 04/21/21 Notable companies reporting before tomorrow's open HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 04/22/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 HCA Healthcare, Inc.
Hot Stocks	Energy Fuels awarded additional $1.75M for feasibility study for DOE » 08:05 04/23/21 04/23 08:05 04/23/21 08:05 UUUU Energy Fuels $5.27 / -0.26 (-4.70%) Energy Fuels announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options UUUU Energy Fuels $5.27 / -0.26 (-4.70%) 04/21/21 Energy Fuels and Hyperion sign MOU for rare earth element production 03/09/21 Energy Fuels announces arrival of first natural monazite ore at White Mesa Mill 03/02/21 Energy Fuels, Neo Performance Materials announce joint venture launch 12/14/20 Energy Fuels enters three-year monazite supply agreement with Chemours UUUU Energy Fuels $5.27 / -0.26 (-4.70%) 03/23/21 H.C. Wainwright Energy Fuels price target raised to $7.25 from $4.50 at H.C. Wainwright 01/13/21 Cantor Fitzgerald Energy Fuels upgraded to Buy from Hold at Cantor Fitzgerald 01/06/21 Cantor Fitzgerald Energy Fuels downgraded to Hold from Buy at Cantor Fitzgerald 12/14/20 Cantor Fitzgerald Cameco downgraded to Hold from Buy at Cantor Fitzgerald 05/26/21 Energy Fuels Inc. 05/26/21 Energy Fuels Inc. UUUU Energy Fuels $5.27 / -0.26 (-4.70%) 04/22/21 Largest borrow rate increases among liquid names 04/20/21 Energy Fuels call volume above normal and directionally bullish 04/16/21 Energy Fuels put volume heavy and directionally bearish 04/09/21 Unusual call flow in option market yesterday

Hot Stocks	Inovio planning for ex-U.S. global Phase 3 trial for INO-4800 » 08:05 04/23/21 04/23 08:05 04/23/21 08:05 INO Inovio $9.13 / -0.02 (-0.22%) Inovio announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options INO Inovio $9.13 / -0.02 (-0.22%) 04/15/21 Inovio's COVID-19 vaccine candidate shows response against all tested variants 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/23/21 Inovio doses first patient in Phase 1B clinical trial for INO-4500 INO Inovio $9.13 / -0.02 (-0.22%) 03/23/21 Fly Intel: Top five analyst initiations 03/23/21 BofA Inovio initiated with a Neutral at BofA 03/02/21 Piper Sandler Piper lowers Inovio target to $7 after 'decidedly negative' update 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target INO Inovio $9.13 / -0.02 (-0.22%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $9.13 / -0.02 (-0.22%) 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 05/13/21 Inovio Pharmaceuticals, Inc INO Inovio $9.13 / -0.02 (-0.22%) 04/20/21 Largest borrow rate increases among liquid names 04/15/21 Unusually active option classes on open April 15th 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish
Hot Stocks	OneSpan CFO Mark Hoyt to leave company » 08:03 04/23/21 04/23 08:03 04/23/21 08:03 OSPN OneSpan $27.98 / +0.32 (+1.16%) OneSpan announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events OSPN OneSpan $27.98 / +0.32 (+1.16%) 04/15/21 Legion files proxy statement and issues letter to OneSpan shareholders OSPN OneSpan $27.98 / +0.32 (+1.16%) 04/15/21 Sidoti OneSpan upgraded to Buy from Neutral at Sidoti 03/31/21 DA Davidson OneSpan initiated with a Buy at DA Davidson as revenue growth accelerates 03/30/21 DA Davidson OneSpan initiated with a Buy at DA Davidson 02/19/21 Sidoti OneSpan downgraded to Neutral from Buy at Sidoti OSPN OneSpan $27.98 / +0.32 (+1.16%) 02/23/21 OneSpan sees FY21 revenue $215M-$225M, consensus $225.1M 02/23/21 OneSpan reports Q4 EPS 3c, consensus 1c 11/02/20 OneSpan sees FY20 revenue $203M-$207M, consensus $233.68M 11/02/20 OneSpan reports Q3 EPS 3c, consensus 5c OSPN OneSpan $27.98 / +0.32 (+1.16%) 11/02/20 Fly Intel: After-Hours Movers 05/04/21 OneSpan - OSPN
Upgrade	Travelzoo upgraded to Outperform from Market Perform at Noble Capital » 08:02 04/23/21 04/23 08:02 04/23/21 08:02 TZOO Travelzoo $14.62 / -0.38 (-2.53%) Noble Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TZOO Travelzoo $14.62 / -0.38 (-2.53%) 04/22/21 Travelzoo expects Q2 to achieve 'significantly higher revenue' 04/22/21 Travelzoo reports 31.8M members worldwide as of March 31 03/31/21 Travelzoo appoints Michele Huban as CFO 03/17/21 Travelzoo expects Q1 result 'close to break-even or a profit' TZOO Travelzoo $14.62 / -0.38 (-2.53%) 03/25/21 Ascendiant Travelzoo upgraded to Buy from Hold at Ascendiant 03/18/21 Noble Capital Travelzoo downgraded to Market Perform from Outperform at Noble Capital 09/14/20 Noble Capital Travelzoo initiated with an Outperform at Noble Capital 09/02/20 Barrington Travelzoo price target raised to $11 from $7.50 at Barrington TZOO Travelzoo $14.62 / -0.38 (-2.53%) 04/22/21 Travelzoo reports Q1 EPS (14c), consensus (2c) 03/17/21 Travelzoo reports Q4 EPS 2c, consensus 1c
Initiation	Clearway Energy initiated with a Buy at Tudor Pickering » 08:02 04/23/21 04/23 08:02 04/23/21 08:02 CWEN Clearway Energy $28.70 / +0.22 (+0.77%) Tudor Pickering initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events CWEN Clearway Energy $28.70 / +0.22 (+0.77%) 04/04/21 Fly Intel: Top five weekend stock stories 02/24/21 Clearway Energy sees direct cash impact of $20M-$30M from weather event 02/16/21 Clearway Energy raises dividend 1.9% to 32.4c 12/22/20 Clearway Energy announces agreements for 1.6GW of renewable energy assets CWEN Clearway Energy $28.70 / +0.22 (+0.77%) 03/30/21 Seaport Global Clearway Energy upgraded to Buy from Neutral at Seaport Global 03/25/21 Wolfe Research Clearway Energy upgraded to Outperform from Peer Perform at Wolfe Research 12/15/20 Seaport Global Clearway Energy downgraded to Neutral after re-rating at Seaport Global 12/15/20 Seaport Global Clearway Energy downgraded to Neutral from Buy at Seaport Global CWEN Clearway Energy $28.70 / +0.22 (+0.77%) 04/03/21 Vulcan, NextEra among stocks to gain from infrastructure plan, Barron's says CWEN Clearway Energy $28.70 / +0.22 (+0.77%) 12/22/20 Fly Intel: After-Hours Movers 05/06/21 Clearway Energy - CWEN 04/29/21 Clearway Energy, Inc.
Hot Stocks	AbbVie receives positive CHMP opinion for VENCLYXTO combination therapy » 08:01 04/23/21 04/23 08:01 04/23/21 08:01 ABBV AbbVie $110.05 / -0.73 (-0.66%) AbbVie announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $110.05 / -0.73 (-0.66%) 04/22/21 AbbVie reports Health Canada approval of Humira for pediatric ulcerative colitis 04/07/21 AbbVie submits regulatory applications for SKYRIZI to FDA, EMA 04/04/21 AbbVie announces extension of review of sNDA of upadacitinib 04/01/21 AbbVie: NEJM publishes 24-week results from Phase 3 RINVOQ study ABBV AbbVie $110.05 / -0.73 (-0.66%) 04/21/21 Citi Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data 04/21/21 Citi Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating 04/06/21 RBC Capital AbbVie transferred with an Outperform at RBC Capital 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler ABBV AbbVie $110.05 / -0.73 (-0.66%) 02/03/21 AbbVie sees FY21 adjusted EPS $12.32-$12.52, consensus $12.18 02/03/21 AbbVie reports Q4 adjusted EPS $2.92, consensus $2.85 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open ABBV AbbVie $110.05 / -0.73 (-0.66%) 04/20/21 California lawyer accuses drugmakers of causing opioid addiction, WSJ reports 03/15/21 AbbVie in discussions to sell $5B women's drug portfolio, Reuters reports 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says ABBV AbbVie $110.05 / -0.73 (-0.66%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/30/21 AbbVie - ABBV 05/07/21 AbbVie Inc. ABBV AbbVie $110.05 / -0.73 (-0.66%) 03/17/21 Unusually active option classes on open March 17th 02/05/21 Unusually active option classes on open February 5th 01/27/21 AbbVie put volume heavy and directionally bearish 11/10/20 AbbVie call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

HON
Today at 08:30

Honeywell - HON Conference Calls
CBAN
Today at 08:30

Colony Bankcorp - CBAN Conference Calls
AXP
Today at 08:30

American Express - AXP Conference Calls
MSBI
Today at 08:30

Midland States - MSBI Conference Calls
FFBC
Today at 08:30

First Financial Bancorp - FFBC Conference Calls
KREF
Today at 08:30

KKR Real Estate Finance Trust Inc. Firm Sponsored Meetings
INTC
Today at 08:30

Technology Industry Meetings
HTH
Today at 09:00

Hilltop Holdings - HTH Conference Calls
PINE
Today at 09:00

Alpine Income Property - PINE Conference Calls
ABCB
Today at 09:00

Ameris Bancorp - ABCB Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One Priced at: $27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham Priced at: $56.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler Priced at: $14.00 6.96M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong Priced at: $130.00 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim Priced at: $150.00 4.78M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NOTV X NOTV Inotiv Spot Secondary Managers: Colliers Priced at: $17.00 2.647M Shares
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR Priced at: $16.00 9.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink Priced at: $17.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA Priced at: $31.00 16.13M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EOLS X EOLS Evolus Spot Secondary Managers: SVB Leerink, Stifel & Cantor Fitzgerald Priced at: $9.50 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NBSE X NBSE NeuBase Therapeutics Spot Secondary Managers: RBC Capital, Oppenheimer & Chardan, National Securities Priced at: $5.00 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB Priced at: $14.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush Priced at: $15.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim Priced at: $17.00 7.353M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist Priced at: $19.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel Priced at: $17.00 11.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDAP X EDAP EDAP TMS Spot Secondary Managers: Piper Sandler Priced at: $6.75 4.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

ICF International management to meet virtually with Barrington

TODAY'S FREE FLY STORIES

Get Full Fly Access